Ticker Details
Absci Corporation Common Stock
IPO Date:	July 22, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.64B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.25 | 5.00%
Avg Daily Range (30 D):	$0.39 | 4.38%
Avg Daily Range (90 D):	$0.38 | 5.55%

Institutional Daily Volume
Avg Daily Volume:	1.92M
Avg Daily Volume (30 D):	2.62M
Avg Daily Volume (90 D):	4.61M

Trade Size
Avg Trade Size (Sh.):	168
Avg Trade Size (Sh.) (30 D):	91
Avg Trade Size (Sh.) (90 D):	129

Institutional Trades
Total Institutional Trades:	483
Avg Institutional Trade:	$1.74M
Avg Institutional Trade (30 D):	$2.29M
Avg Institutional Trade (90 D):	$2.02M
Avg Institutional Trade Volume:	.34M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.04M
Avg Closing Trade (30 D):	$2.88M
Avg Closing Trade (90 D):	$2.9M
Avg Closing Volume:	396.96K

News

Jun 16, 2026 @ 12:45 PM The Quiet Bottleneck in AI Drug Discovery Isn't th... Source: Equity Insider

May 13, 2026 @ 2:03 PM AMD Reveals A $6.5 Million Marvell Bet That's Alre... Source: Erica Kollmann

May 5, 2026 @ 12:11 AM Absci Announces Inducement Grant Under Nasdaq List... Source: Na

Mar 3, 2026 @ 1:00 PM Absci Strengthens Clinical Leadership with Appoint... Source: Na

Oct 29, 2025 @ 8:05 PM Absci to Report Business Updates and Third Quarter... Source: Globe Newswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.79	$-.21	$-.19
Diluted EPS	$-.79	$-.21	$-.19
Revenue	$1.56M	$.32M	$.22M
Gross Profit
Net Income / Loss	$-121.08M	$-33.21M	$-29.6M
Operating Income / Loss	$-126.2M	$-34.16M	$-30.85M
Cost of Revenue
Net Cash Flow	$53.63M	$99.23M	$-11.39M
PE Ratio